Cart
sales@molnova.com
BMS-813160
CAS No. 1286279-29-5
BMS-813160 ( —— )
Catalog No. M17924 CAS No. 1286279-29-5
BMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 125 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 323 | In Stock |
|
| 50MG | 537 | In Stock |
|
| 100MG | 767 | In Stock |
|
| 500MG | 1557 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBMS-813160
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
-
DescriptionBMS-813160 is the first dualCCR2/CCR5antagonist to enter Clinical development for cardiovascular.
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorCCR2;CCR5
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1286279-29-5
-
Formula Weight484.64
-
Molecular FormulaC25H40N8O2
-
Purity98%
-
SolubilityDMSO : 25 mg/mL 51.58 mM;
-
SMILESCC(C)(C)N[C@@H]1CC[C@@H]([C@H](NC(C)=O)C1)N4CC[C@H](Nc2ncnc3cc(nn23)C(C)(C)C)C4=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.
molnova catalog
related products
-
Mitiglinide calcium
An insulin secretion stimulator by closing the ATP-sensitive potassium KATP channels in pancreatic β cells.
-
P-1075
P-1075 is a potent sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-KIR6) activator (EC50 = 45 nM).
-
RU-TRAAK-2
RU-TRAAK-2 is a reversible inhibitor of TWIK-related arachidonic acid-stimulated K+ channel with no activity for non-K2P channels including Kv1.2, GIRK2, and Slo1.
